The treatment of hepatitis C has dramatically improved over the past decade. Unlike any
other chronic viral infection, a significant proportion of patients with chronic hepatitis C can …

Since hyaluronate (HA) was firstly isolated from the vitreous of bovine eyes in 1934, HA has
been widely investigated for various biomedical applications. As a naturally-occurring …

Clinicians are required to assess abnormal liver chemistries on a daily basis. The most
common liver chemistries ordered are serum alanine aminotransferase (ALT), aspartate …

Background The hepatitis C virus (HCV) is a major public health problem and a leading
cause of chronic liver disease. 5 An estimated 180 million people are infected worldwide. 6 …

BACKGROUND & AIMS:: A sustained virologic response (SVR) to therapy for hepatitis C
virus (HCV) infection is defined as the inability to detect HCV RNA 24 weeks after …

Polyethylene glycol (PEG) is a biocompatible polymer that is often attached to therapeutic
molecules to improve bioavailability and therapeutic efficacy. Although antibodies with …

Abreviaturas usadas en este Trabajo: IC: intervalo de confianza; RVT: respuesta virológica
temprana; TAAA: terapia antirretroviral altamente activa; IHA: índice histiológico activo; VIH …

Chronic liver diseases are very common worldwide, particularly those linked to viral hepatitis
and to alcoholic and non-alcoholic fatty liver. Their natural history is variable and long-term …

Chronic hepatitis C (HCV) infection is currently one of the most clinically relevant
comorbidities in the HIV population; overall, it affects one third of HIV-positive individuals [1] …

The current preferred treatment for patients with hepatitis C virus (HCV) is combination
therapy consisting of pegylated interferon alfa and ribavirin (RBV) for 24–48 weeks …